John W Seal

Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical Characterization.

D. J. Price, M. Thomson, R. Crosby, 2012, ACS medicinal chemistry letters.

Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase **

Douglas W. Thomson, Rodrigo F. Ortiz-Meoz, G. Bergamini, 2020, Chembiochem : a European journal of chemical biology.

Characterization of apo-form selective inhibition of indoleamine 2,3-dioxygenase

Douglas W. Thomson, Rodrigo F. Ortiz-Meoz, G. Bergamini, 2020, bioRxiv.

Characterization of novel inhibition of indoleamine 2,3-dioxygenase by targeting its apo form.

Douglas W. Thomson, Rodrigo F. Ortiz-Meoz, G. Bergamini, 2018 .

Pyridopyrimidinone inhibitors of HIV-1 RNase H.

L. Leesnitzer, K. Hightower, B. Johns, 2014, European journal of medicinal chemistry.

Hepatitis C replication inhibitors that target the viral NS4B protein.

D. J. Price, R. Hamatake, Z. Hong, 2014, Journal of medicinal chemistry.

Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein.

D. J. Price, J. Pouliot, A. Maynard, 2014, Bioorganic & medicinal chemistry letters.